Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C.

Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.

PMID:
30120041
2.

Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation.

Schernberg A, Nivet A, Dhermain F, Ammari S, Escande A, Pallud J, Louvel G, Deutsch E.

Clin Transl Radiat Oncol. 2018 Apr 13;10:47-52. doi: 10.1016/j.ctro.2018.04.002. eCollection 2018 Mar.

3.

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.

Mekki A, Dercle L, Lichtenstein P, Marabelle A, Michot JM, Lambotte O, Le Pavec J, De Martin E, Balleyguier C, Champiat S, Ammari S.

Eur J Cancer. 2018 Jun;96:91-104. doi: 10.1016/j.ejca.2018.03.006. Epub 2018 Apr 23.

PMID:
29698933
4.

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.

Cabel L, Fuerea A, Lacroix L, Baldini C, Martin P, Hollebecque A, Postel-Vinay S, Varga A, Balheda R, Gazzah A, Michot JM, Marabelle A, Rouleau E, Solary E, De Baere T, Angevin E, Armand JP, Michiels S, Scoazec JY, Ammari S, André F, Soria JC, Massard C, Verlingue L.

Oncotarget. 2018 Jan 12;9(11):9741-9750. doi: 10.18632/oncotarget.24188. eCollection 2018 Feb 9.

5.

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae.

Sun R, Koubaa I, Limkin EJ, Dumas I, Bentivegna E, Castanon E, Gouy S, Baratiny C, Monnot F, Maroun P, Ammari S, Zareski E, Balleyguier C, Deutsch É, Morice P, Haie-Meder C, Chargari C.

Oncotarget. 2018 Jan 18;9(10):9299-9310. doi: 10.18632/oncotarget.24271. eCollection 2018 Feb 6.

6.

Can we trust the calculation of texture indices of CT images? A phantom study.

Caramella C, Allorant A, Orlhac F, Bidault F, Asselain B, Ammari S, Jaranowski P, Moussier A, Balleyguier C, Lassau N, Pitre-Champagnat S.

Med Phys. 2018 Apr;45(4):1529-1536. doi: 10.1002/mp.12809. Epub 2018 Mar 13.

PMID:
29443389
7.

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.

Dercle L, Ammari S, Seban RD, Schwartz LH, Houot R, Labaied N, Mokrane FZ, Lazarovici J, Danu A, Marabelle A, Ribrag V, Michot JM.

Eur J Cancer. 2018 Mar;91:136-144. doi: 10.1016/j.ejca.2017.12.015.

PMID:
29360605
8.

Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases.

Nardin C, Mateus C, Texier M, Lanoy E, Hibat-Allah S, Ammari S, Robert C, Dhermain F.

Melanoma Res. 2018 Apr;28(2):111-119. doi: 10.1097/CMR.0000000000000413.

PMID:
29356789
9.

Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?

Louvel G, Bahleda R, Ammari S, Le Péchoux C, Levy A, Massard C, Le Pavec J, Champiat S, Deutsch E.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701737. doi: 10.1183/13993003.01737-2017. Print 2018 Jan. No abstract available.

PMID:
29301923
10.

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.

Delahousse J, Verlingue L, Broutin S, Legoupil C, Touat M, Doucet L, Ammari S, Lacroix L, Ducreux M, Scoazec JY, Malka D, Paci A, Hollebecque A.

Eur J Cancer. 2018 Feb;90:83-91. doi: 10.1016/j.ejca.2017.11.024. Epub 2018 Jan 4.

PMID:
29274619
11.

Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?

Sun R, Danlos FX, Ammari S, Louvel G, Dhermain F, Champiat S, Lambotte O, Deutsch E.

J Immunother Cancer. 2017 Dec 19;5(1):96. doi: 10.1186/s40425-017-0304-8.

12.

Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.

Schernberg A, Dhermain F, Ammari S, Dumont SN, Domont J, Patrikidou A, Pallud J, Dezamis É, Deutsch É, Louvel G.

Cancer Radiother. 2018 Feb;22(1):9-16. doi: 10.1016/j.canrad.2017.06.013. Epub 2017 Dec 6.

PMID:
29217134
13.

Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.

Tazdait M, Mezquita L, Lahmar J, Ferrara R, Bidault F, Ammari S, Balleyguier C, Planchard D, Gazzah A, Soria JC, Marabelle A, Besse B, Caramella C.

Eur J Cancer. 2018 Jan;88:38-47. doi: 10.1016/j.ejca.2017.10.017. Epub 2017 Nov 26.

PMID:
29182990
14.

[Pulmonary tumor thrombotic microangiopathy].

Merad M, Alibay A, Ammari S, Antoun S, Bouguerba A, Ayed S, Vincent F; pour le Grrr-OH.

Rev Mal Respir. 2017 Dec;34(10):1045-1057. doi: 10.1016/j.rmr.2017.02.008. Epub 2017 Nov 17. Review. French.

PMID:
29153757
15.

Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.

Dercle L, Hartl D, Rozenblum-Beddok L, Mokrane FZ, Seban RD, Yeh R, Bidault F, Ammari S.

Eur Radiol. 2018 Apr;28(4):1761-1770. doi: 10.1007/s00330-017-5063-x. Epub 2017 Oct 30.

PMID:
29086023
16.

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors).

Sun R, Champiat S, Dercle L, Aspeslagh S, Castanon E, Limkin EJ, Baldini C, Postel-Vinay S, Hollebecque A, Massard C, Ammari S, Deutsch E, Soria JC, Marabelle A, Ferté C.

Eur J Cancer. 2017 Oct;84:202-211. doi: 10.1016/j.ejca.2017.07.033. Epub 2017 Aug 18.

PMID:
28826073
17.

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence.

Dercle L, Ammari S, Bateson M, Durand PB, Haspinger E, Massard C, Jaudet C, Varga A, Deutsch E, Soria JC, Ferté C.

Sci Rep. 2017 Aug 11;7(1):7952. doi: 10.1038/s41598-017-08310-5.

18.

18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.

Dercle L, Seban RD, Lazarovici J, Schwartz LH, Houot R, Ammari S, Danu A, Edeline V, Marabelle A, Ribrag V, Michot JM.

J Nucl Med. 2018 Jan;59(1):15-24. doi: 10.2967/jnumed.117.193011. Epub 2017 Jun 8.

19.

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Massard C, Michiels S, Ferté C, Le Deley MC, Lacroix L, Hollebecque A, Verlingue L, Ileana E, Rosellini S, Ammari S, Ngo-Camus M, Bahleda R, Gazzah A, Varga A, Postel-Vinay S, Loriot Y, Even C, Breuskin I, Auger N, Job B, De Baere T, Deschamps F, Vielh P, Scoazec JY, Lazar V, Richon C, Ribrag V, Deutsch E, Angevin E, Vassal G, Eggermont A, André F, Soria JC.

Cancer Discov. 2017 Jun;7(6):586-595. doi: 10.1158/2159-8290.CD-16-1396. Epub 2017 Apr 1.

20.

Abstracts of the 40th National Congress of Medicine Tunis, 19-20 October 2017.

Abdallah M, Abdelaziz A, Abdelaziz O, Abdelhedi N, Abdelkbir A, Abdelkefi M, Abdelmoula L, Abdennacir S, Abdennadher M, Abidi H, Abir Hakiri A, Abou El Makarim S, Abouda M, Achour W, Aichaouia C, Aissa A, Aissa Y, Aissi W, Ajroudi M, Allouche E, Aloui H, Aloui D, Amdouni F, Ammar Y, Ammara Y, Ammari S, Ammous A, Amous A, Amri A, Amri M, Amri R, Annabi H, Antit S, Aouadi S, Arfaoui A, Assadi A, Attia L, Attia M, Attia L, Ayadi I, Ayadi Dahmane I, Ayari A, Azzabi S, Azzouz H, B Mefteh N, B Salah C, Baccar H, Bachali A, Bahlouli M, Bahri G, Baïli H, Bani M, Bani W, Bani MA, Bassalah E, Bawandi R, Bayar M, Bchir N, Bechraoui R, Béji M, Beji R, Bel Haj Yahia D, Belakhel S, Belfkih H, Belgacem O, Belgacem N, Belhadj A, Beltaief N, Beltaief N, Ben Abbes M, Ben Abdelaziz A, Ben Ahmed I, Ben Aissia N, Ben Ali M, Ben Ammar H, Ben Ammou B, Ben Amor A, Ben Amor M, Benatta M, Ben Ayed N, Ben Ayoub W, Ben Charrada N, Ben Cheikh M, Ben Dahmen F, Ben Dhia M, Ben Fadhel S, Ben Farhat L, Ben Fredj Ismail F, Ben Hamida E, Ben Hamida Nouaili E, Ben Hammamia M, Ben Hamouda A, Ben Hassine L, Ben Hassouna A, Ben Hasssen A, Ben Hlima M, Ben Kaab B, Ben Mami N, Ben Mbarka F, Ben Mefteh N, Ben Kahla N, Ben Mrad M, Ben Mustapha N, Ben Nacer M, Ben Neticha K, Ben Othmen E, Ben Rhouma S, Ben Rhouma M, Ben Saadi S, Ben Safta A, Ben Safta Z, Ben Salah C, Ben Salah N, Ben Sassi S, Ben Sassi J, Ben Tekaya S, Ben Temime R, Ben Tkhayat A, Ben Tmim R, Ben Yahmed Y, Ben Youssef S, Ben Ali M, Ben Atta M, Ben Safta Z, Ben Salah M, Berrahal I, Besbes G, Bezdah L, Bezzine A, Bezzine A, Bokal Z, Borsali R, Bouasker I, Boubaker J, Bouchekoua M, Bouden F, Boudiche S, Boukhris I, Bouomrani S, Bouraoui S, Bouraoui S, Bourgou S, Boussabeh E, Bouzaidi K, Chaker K, Chaker L, Chaker A, Chaker F, Chaouech N, Charfi M, Charfi MR, Charfi F, Chatti L, Chebbi F, Chebbi W, Cheikh R, Cheikhrouhou S, Chekir J, Chelbi E, Chelly I, Chelly B, Chemakh M, Chenik S, Cheour M, Cheour M, Cherif E, Cherif Y, Cherif W, Cherni R, Chetoui A, Chihaoui M, Chiraz Aichaouia C, Dabousii S, Daghfous A, Daib A, Daib N, Damak R, Daoud N, Daoud Z, Daoued N, Debbabi H, Demni W, Denguir R, Derbel S, Derbel B, Dghaies S, Dhaouadi S, Dhilel I, Dimassi K, Dougaz A, Dougaz W, Douik H, Douik El Gharbi L, Dziri C, El Aoud S, El Hechmi Z, El Heni A, ELaoud S, Elfeleh E, Ellini S, Ellouz F, Elmoez Ben O, Ennaifer R, Ennaifer S, Essid M, Fadhloun N, Farhat M, Fekih M, Fourati M, Fteriche F, G Hali O, Galai S, Gara S, Garali G, Garbouge W, Garbouj W, Ghali O, Ghali F, Gharbi E, Gharbi R, Ghariani W, Gharsalli H, Ghaya Jmii G, Ghédira F, Ghédira A, Ghédira H, Ghériani A, Gouta EL, Guemira F, Guermazi E, Guesmi A, Hachem J, Haddad A, Hakim K, Hakiri A, Hamdi S, Hamed W, Hamrouni S, Hamza M, Haouet S, Hariz A, Hendaoui L, Hfaidh M, Hriz H, Hsairi M, Ichaoui H, Issaoui D, Jaafoura H, Jazi R, Jazia R, Jelassi H, Jerraya H, Jlassi H, Jmii G, Jouini M, Kâaniche M, Kacem M, Kadhraoui M, Kalai M, Kallel K, Kammoun O, Karoui M, Karouia S, Karrou M, Kchaou A, Kchaw R, Kchir N, Kchir H, Kechaou I, Kerrou M, Khaled S, Khalfallah N, Khalfallah M, Khalfallah R, Khamassi K, Kharrat M, Khelifa E, Khelil M, Khelil A, Khessairi N, Khezami MA, Khouni H, Kooli C, Korbsi B, Koubaa MA, Ksantini R, Ksentini A, Ksibi I, Ksibi J, Kwas H, Laabidi A, Labidi A, Ladhari N, Lafrem R, Lahiani R, Lajmi M, Lakhal J, Laribi M, Lassoued N, Lassoued K, Letaif F, Limaïem F, Maalej S, Maamouri N, Maaoui R, Maâtallah H, Maazaoui S, Maghrebi H, Mahfoudhi S, Mahjoubi Y, Mahjoubi S, Mahmoud I, Makhlouf T, Makni A, Mamou S, Mannoubi S, Maoui A, Marghli A, Marrakchi Z, Marrakchi J, Marzougui S, Marzouk I, Mathlouthi N, Mbarek K, Mbarek M, Meddeb S, Mediouni A, Mechergui N, Mejri I, Menjour MB, Messaoudi Y, Mestiri T, Methnani A, Mezghani I, Meziou O, Mezlini A, Mhamdi S, Mighri M, Miled S, Miri I, Mlayeh D, Moatemri Z, Mokaddem W, Mokni M, Mouhli N, Mourali MS, Mrabet A, Mrad F, Mrouki M, Msaad H, Msakni A, Msolli S, Mtimet S, Mzabi S, Mzoughi Z, Naffeti E, Najjar S, Nakhli A, Nechi S, Neffati E, Neji H, Nouira Y, Nouira R, Omar S, Ouali S, Ouannes Y, Ouarda F, Ouechtati W, Ouertani J, Ouertani J, Ouertani H, Oueslati A, Oueslati J, Oueslati I, Oueslati A, Rabai B, Rahali H, Rbia E, Rebai W, Regaïeg N, Rejeb O, Rhaiem W, Rhimi H, Riahi I, Ridha R, Robbena L, Rouached L, Rouis S, Safer M, Saffar K, Sahli H, Sahraoui G, Saidane O, Sakka D, Salah H, Sallami S, Salouage I, Samet A, Sammoud K, Sassi Mahfoudh A, Sayadi C, Sayhi A, Sebri T, Sedki Y, Sellami A, Serghini M, Sghaier I, Skouri W, Skouri W, Slama I, Slimane H, Slimani O, Souhail O, Souhir S, Souissi A, Souissi R, Taboubi A, Talbi G, Tbini M, Tborbi A, Tekaya R, Temessek H, Thameur M, Touati A, Touinsi H, Tounsi A, Tounsia H, Trabelsi S, Trabelsi S, Triki A, Triki M, Turki J, Turki K, Twinsi H, Walha Y, Wali J, Yacoub H, Yangui F, Yazidi M, Youssef I, Zaier A, Zainine R, Zakhama L, Zalila H, Zargouni H, Zehani A, Zeineb Z, Zemni I, Zghal M, Ziadi J, Zid Z, Znagui I, Zoghlami C, Zouaoui C, Zouari B, Zouiten L, Zribi H.

Tunis Med. 2017 Novembre;95(11):1002-1070. No abstract available.

21.

Blue Lymphangitis of the Breast after Breast Cancer: Case Report.

Arfi A, Clavier A, Honart JF, Ammari S, Merabet Z, Mateus C, Arfi-Rouche J.

Breast J. 2017 May;23(3):348-351. doi: 10.1111/tbj.12738. Epub 2016 Dec 3.

PMID:
27914118
22.

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

Champiat S, Dercle L, Ammari S, Massard C, Hollebecque A, Postel-Vinay S, Chaput N, Eggermont A, Marabelle A, Soria JC, Ferté C.

Clin Cancer Res. 2017 Apr 15;23(8):1920-1928. doi: 10.1158/1078-0432.CCR-16-1741. Epub 2016 Nov 8.

23.

Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody.

Michot JM, Mazeron R, Dercle L, Ammari S, Canova C, Marabelle A, Rose S, Rubin E, Deutsch E, Soria JC, Ribrag V, Levy A.

Eur J Cancer. 2016 Oct;66:91-4. doi: 10.1016/j.ejca.2016.06.017. Epub 2016 Aug 18. No abstract available.

PMID:
27544928
24.

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.

Dercle L, Ammari S, Champiat S, Massard C, Ferté C, Taihi L, Seban RD, Aspeslagh S, Mahjoubi L, Kamsu-Kom N, Robert C, Marabelle A, Schlumberger M, Soria JC, Postel-Vinay S.

Eur J Cancer. 2016 Sep;65:33-42. doi: 10.1016/j.ejca.2016.05.031. Epub 2016 Jul 21.

PMID:
27451022
25.

Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.

Chemama S, Bayar MA, Lanoy E, Ammari S, Stoclin A, Goéré D, Elias D, Raynard B, Antoun S.

Ann Surg Oncol. 2016 Nov;23(12):3891-3898. Epub 2016 Jun 28.

PMID:
27352205
26.

Diaphragmatic Hernia After Lung Percutaneous Radiofrequency Ablation: Incidence and Risk Factors—Reply.

Alberti N, Buy X, Desjardin M, Al Ammari S, Cazzato RL, Bechade D, Desolneux G, Michot A, Palussiere J.

Cardiovasc Intervent Radiol. 2016 Feb;39(2):318-9. No abstract available.

PMID:
26493823
27.

Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Dercle L, Chisin R, Ammari S, Gillebert Q, Ouali M, Jaudet C, Delord JP, Dierickx L, Zerdoud S, Schlumberger M, Courbon F.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):397-408. doi: 10.1007/s00259-014-2938-9. Epub 2014 Nov 1.

PMID:
25367748
28.

LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancer.

Arrondeau J, Ammari S, Besse B, Soria JC.

J Thorac Oncol. 2014 Aug;9(8):e62-3. doi: 10.1097/JTO.0000000000000174. No abstract available.

29.

Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson.

Fournier L, Ammari S, Thiam R, Cuénod CA.

Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):689-703. doi: 10.1016/j.diii.2014.05.002. Epub 2014 Jun 17.

30.

Radiological evaluation of response to treatment: application to metastatic renal cancers receiving anti-angiogenic treatment.

Ammari S, Thiam R, Cuenod CA, Oudard S, Hernigou A, Grataloup C, Siauve N, Medioni J, Fournier LS.

Diagn Interv Imaging. 2014 Jun;95(6):527-39. doi: 10.1016/j.diii.2013.01.019. Epub 2014 Jun 3. Review.

31.

Whole body MRI in paediatric oncology.

Canale S, Vilcot L, Ammari S, Lemery M, Bidault F, Balleyguier C, Caramella C, Dromain C.

Diagn Interv Imaging. 2014 Jun;95(6):541-50. doi: 10.1016/j.diii.2013.11.002. Epub 2014 Apr 3. Review.

32.

Diaphragmatic hernia after lung percutaneous radiofrequency ablation: incidence and risk factors.

Alberti N, Ferretti G, Buy X, Desjardin M, Al Ammari S, Cazzato RL, Monnin-Bares V, Bechade D, Desolneux G, Michot A, Palussiere J.

Cardiovasc Intervent Radiol. 2014 Dec;37(6):1516-22. doi: 10.1007/s00270-014-0854-9. Epub 2014 Feb 12.

PMID:
24519640
33.

Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.

Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C, Ammari S, Soria JC.

Clin Cancer Res. 2014 Jan 1;20(1):246-52. doi: 10.1158/1078-0432.CCR-13-2098. Epub 2013 Nov 15.

34.

Malignant head/neck paragangliomas. Comparative study.

Mediouni A, Ammari S, Wassef M, Gimenez-Roqueplo AP, Laredo JD, Duet M, Tran Ba Huy P, Oker N.

Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Jun;131(3):159-66. doi: 10.1016/j.anorl.2013.05.003. Epub 2013 Nov 14.

35.

Reversible posterior leukoencephalopathy syndrome induced by axitinib.

Levy A, Benmoussa L, Ammari S, Albiges L, Escudier B.

Clin Genitourin Cancer. 2014 Feb;12(1):e33-4. doi: 10.1016/j.clgc.2013.08.008. Epub 2013 Oct 14. No abstract available.

PMID:
24135633
36.

Breast elastography: the technical process and its applications.

Balleyguier C, Ciolovan L, Ammari S, Canale S, Sethom S, Al Rouhbane R, Vielh P, Dromain C.

Diagn Interv Imaging. 2013 May;94(5):503-13. doi: 10.1016/j.diii.2013.02.006. Epub 2013 Apr 22. Review.

37.

Disseminated bone involvement in systemic sarcoidosis mimicking bone metastases. A multimodality imaging approach.

Khiar A, Duet M, Ammari S, Brouland JP, Lioté F, Paycha F.

Joint Bone Spine. 2011 Mar;78(2):216-7. doi: 10.1016/j.jbspin.2010.08.003. Epub 2010 Nov 17. No abstract available.

PMID:
21087877
38.

Characterization of Salmonella Enteritidis isolated from foods and patients in northern Morocco.

Ammari S, Laglaoui A, En-nanei L, Bertrand S, Wildemauwe C, Barrijal S, Abid M.

J Infect Dev Ctries. 2009 Oct 26;3(9):695-703.

39.

Isolation, drug resistance and molecular characterization of Salmonella isolates in northern Morocco.

Ammari S, Laglaoui A, En-Nanei L, Bertrand S, Wildemauwe C, Barrijal S, Abid M.

J Infect Dev Ctries. 2009 Feb 28;3(1):41-9.

40.

Verrucous carcinoma of the skin: case report with literature review.

Simatos G, Savvanis G, Paraskevaides M, Vechinni G, Porfiris E, Arkoulis N, Tzerbinis H, Mastoraki S, Tsikkinis C, Ammari S, Nissiotis A.

J BUON. 2009 Jan-Mar;14(1):139-41. Review.

PMID:
19365886
41.

Malignant paraganglioma of the abdomen.

Simatos G, Savanis G, Arapantoni-Dadioti P, Ammari S, Tsikkinis C, Mylonas A, Leontara V, Nissiotis A.

J BUON. 2006 Apr-Jun;11(2):233-5.

PMID:
17318977
42.

Gastrointestinal tract metastasis as first presentation of breast cancer.

Savanis G, Simatos G, Tzaida O, Tsikkinis C, Ammari S, Mylonas A, Kafasis E, Nisiotis A.

J BUON. 2006 Jan-Mar;11(1):79-81.

PMID:
17318957
43.

Abdominal metastases from lung cancer resulting in small bowel perforation: report of three cases.

Savanis G, Simatos G, Lekka I, Ammari S, Tsikkinis C, Mylonas A, Kafasis E, Nissiotis A.

Tumori. 2006 Mar-Apr;92(2):185-7.

PMID:
16724702

Supplemental Content

Loading ...
Support Center